Daily FNArena News

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Australian healthcare stocks

Pantoro Gold’s operational setbacks and missed production targets overshadow a high-quality gold asset

Artificial intelligence is poised to change the world, but identifying who will ultimately create shareholder value out of this new technology remains a challenge, says Robert M. Almeida, Portfolio Manager and Global Investment Strategist MFS Investment Management

While SpaceX is reshaping the long-term telecommunications landscape, analysts believe Aussie Broadband’s near-term earnings outlook and valuation remain attractive

Middle East conflict accelerating the global energy transition, although it’s not that easy; Macquarie’s fossil fuel financing questioned; US slavery tariff exposes Australian weakness; winners & losers in human capital management

Supplier surveys and consumer spending data have analysts divided over supermarket valuations and where the best value lays across the consumer sector

Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, ASX200, gold and crude oil

While one broker has turned more cautious on ResMed due to a one-off cost and risk of rising competition, analysts broadly welcome the MatrixCare sale as a strategic refocus backed by a sizeable shareholder return

Rio Tinto shares appear to be stabilising after their recent decline. Fairmont Equities’ Michael Gable sees potential for a near-term recovery